Institute For The Study Of Aging And Elan Pharmaceuticals Announce Winners Of New Alzheimer's Disease Drug Discovery Award Program

The Institute for the Study of Aging (ISOA), a biomedical venture philanthropy founded by the Estee Lauder family, and Elan Pharmaceuticals, Inc., a neuroscience-based biotechnology company, are pleased to announce the winners of their new research award program, Novel Approaches to Drug Discovery for Alzheimer's Disease. Four recipients were selected from a highly competitive pool of 45 scientists from 12 countries.